Effects of nisoldipine on cytosolic calcium, platelet aggregation, and coagulation/fibrinolysis in patients with coronary artery disease

Angiology

Volumn 48, Issue 6, 1997, Pages 515-521

  Fujinishi, Akiko ^a   Takahara, Kazuo ^a   Ohba, Chizuko ^a   Nakashima, Yasuhide ^a   Kuroiwa, Akio ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CALCIUM ANTAGONIST; DIHYDROPYRIDINE DERIVATIVE; NISOLDIPINE; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; CALCIUM CELL LEVEL; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; DRUG EFFECT; DRUG SCREENING; FEMALE; FIBRINOLYSIS; HUMAN; MALE; THROMBOCYTE AGGREGATION;

EID: 0030910058     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331979704800606     Document Type: Article

References (28)

1. Erne P, Bolli P, Burgisser E, et al: Correlation of platelet calcium with blood pressure. Effect of anti-hypertensive therapy. N Engl J Med 310:1084-1088, 1984.
2. 2 and thrombin (abstract). Circulation 90:I-302, 1994.
3. Mustard JF, Perry DW, Ardlie NG, et al: Preparation of suspensions of washed platelets from humans. Br J Hematol 22:193-204, 1972.
4. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450, 1985.
5. Born GVR: Aggregation blood platelets by adenosine diphosphate and its reversal. Nature 194:927-928, 1962.
6. Files JC: Studies of human platelet α-granule release in vivo. Blood 58:607-618, 1981.
7. Bergsdorf N, Nilsson T, Wallen P: An enzyme-linked immunosorbent assay for determination of tissue plasminogen activator applied to patients with thromboembolic disease. Thromb Hemost 50:740-744, 1983.
8. Pelzer H, Schwarz A, Heimburger N: Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay. Thromb Hemostas 59:101-106, 1988.
9. Elms MJ, Bunce IH, Bundesen PG, et al: Measurement of crosslinked fibrin degradation products: An immunoassay using monoclonal antibodies. Thromb Hemostas 50:591-594, 1983.
10. Kodama S, Uchijima E, Nagai M, et al: One-step sandwich immunoassay for soluble human thrombomodulin using monoclonal antibodies. Clin Chim Acta 192:191-199, 1990.
11. Rink TJ, Sage SO: Calcium signaling in human platelets. Annu Rev Physiol 52:431-449, 1990.
12. Kroll MH, Schafer A: Biochemical mechanisms of platelet activation. Blood 74:1181-1195, 1989.
13. Penner R, Fasolato C, Hoth M: Calcium influx and its control by calcium release. Curr Opin Neurobiol 3:368-374, 1993.
14. 2+ influx: How many mechanisms for how many channels? Trends Pharmacol Sci 15:77-83, 1994.
15. 2 formation. Comparison with diltiazem, nifedipine and verapamil. Thromb Res 63:457-462, 1991.
16. 2-induced aggregation of human platelets. Circulation 73:847-854, 1986.
17. Avdonin PV, Men'shikov MY, Svitina-Ulitina IV, et al: Blocking of the receptor-stimulated calcium entry into human platelets by verapamil and nicardipine. Thromb Res 52:587-597, 1988.
18. Pales J, Palacios-Araus L, Lopez A, et al: Effects of dihydropyridines and inorganic calcium blockers on aggregation and on intracellular free calcium in platelets. Biochim Biophys Acta 1064:169-174, 1991.
19. Lechi A, Lechi G, Bonadonna G, et al: Increased basal and thrombin-induced free calcium in platelets of essential hypertensive patients. Hypertension 9:230-235, 1987.
20. Cooper RS, Shamsi N, Katz S: Intracellular calcium and sodium in hypertensive patients. Hypertension 9:224-229, 1987.
21. Lindner A, Kenny M, Meacham AJ: Effects of a circulating factor in a patient with essential hypertension on intracellular-free calcium in normal platelets. N Engl J Med 316:509-513, 1987.
22. Scherrer U, Nussberger J, Torriani S, et al: Effects of weight reduction in moderately overweight patients on recorded ambulatory blood pressure and free cytosolic platelet calcium. Circulation 83:552-558, 1991.
23. Salmasi A-M, Salmasi S, et al: Improvement of silent myocardial ischemia and reduction of plasma fibrinogen during nisoldipine therapy in occult coronary arterial disease. Int J Cardiol 31:71-80, 1991.
24. Dale J, Landmark KH: The effects of nifedipine, a calcium antagonist, on platelet function. Am Heart J 105:103-105, 1983.
25. Mikhailidis DP, Barradas MA, Mier A, et al: Platelet function in patients admitted with a diagnosis of myocardial infarction. Angiology 38:36-45, 1987.
26. Jones CR, Pasanisi F, Elliott HL, et al: Effects of verapamil and nisoldipine on human platelets: In vivo and in vitro studies. Br J Clin Pharmacol 20:191-196, 1985.
27. Patrone C: Biosynthesis and pharmacological modulation of thromboxane in humans. Circulation 81: I-12-I-15, 1990.
28. 1α in both young male smokers and nonsmokers. Am Heart J 119:1267-1273, 1990.